Abbreviations
- EB:
-
Embryoid body
- EBIO:
-
1-Ethyl-2-benzimidazolinone
- ESC:
-
Embryonic stem cell
- Hcn4:
-
Hyperpolarization-activated cyclic nucleotide-gated channel 4
- iPSC:
-
Induced pluripotent stem cell
- MEF:
-
Mouse embryonic fibroblast
- NGFP:
-
Nanog-EGFP-iPSCs
- SKCa:
-
Calcium activated potassium channel
- TIPS:
-
Tail-tip murine fibroblast-derived iPS-cells
References
Cingolani, L. A., Gymnopoulos, M., Boccaccio, A., Stocker, M., & Pedarzani, P. (2002). Developmental regulation of small-conductance Ca2± activated K+ channel expression and function in rat Purkinje neurons. Journal of Neuroscience, 22(11), 4456–4467.
Xia, X. M., Fakler, B., Rivard, A., Wayman, G., Johnson-Pais, T., Keen, J. E., et al. (1998). Mechanism of calcium gating in small-conductance calcium-activated potassium channels. Nature, 395(6701), 503–507.
Murry, C. E., & Keller, G. (2008). Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell, 132(4), 661–680.
Perino, M. G., Yamanaka, S., Li, J., Wobus, A. M., & Boheler, K. R. (2008). Cardiomyogenic stem and progenitor cell plasticity and the dissection of cardiopoiesis. Journal of Molecular and Cellular Cardiology, 45(4), 475–494.
Bruce, S. J., Gardiner, B. B., Burke, L. J., Gongora, M. M., Grimmond, S. M., & Perkins, A. C. (2007). Dynamic transcription programs during ES cell differentiation towards mesoderm in serum versus serum-freeBMP4 culture. BMC Genomics, 8, 365. doi:10.1186/1471-2164-8-365.
Wiles, M. V., & Johansson, B. M. (1999). Embryonic stem cell development in a chemically defined medium. Experimental Cell Research, 247(1), 241–248. doi:10.1006/excr.1998.4353.
Sachlos, E., & Auguste, D. T. (2008). Embryoid body morphology influences diffusive transport of inductive biochemicals: a strategy for stem cell differentiation. Biomaterials, 29(34), 4471–4480.
Clarke, L., & van der Kooy, D. (2009). A safer stem cell: Inducing pluripotency. Nature Medicine, 15(9), 1001–1002. doi:10.1038/nm0909-1001.
Takahashi, K., & Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126(4), 663–676.
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., et al. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131(5), 861–872. doi:10.1016/j.cell.2007.11.019.
Itzhaki, I., Maizels, L., Huber, I., Zwi-Dantsis, L., Caspi, O., Winterstern, A., et al. (2011). Modelling the long QT syndrome with induced pluripotent stem cells. Nature, 471(7337), 225–229. doi:10.1038/nature09747.
Zhang, J., Wilson, G. F., Soerens, A. G., Koonce, C. H., Yu, J., Palecek, S. P., et al. (2009). Functional cardiomyocytes derived from human induced pluripotent stem cells. Circulation Research, 104(4), e30–e41. doi:10.1161/CIRCRESAHA.108.192237.
Meissner, A., Wernig, M., & Jaenisch, R. (2007). Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nature Biotechnology, 25(10), 1177–1181.
Ying, Q. L., Stavridis, M., Griffiths, D., Li, M., & Smith, A. (2003). Conversion of embryonic stem cells into neuroectodermal precursors in adherent monoculture. Nature Biotechnology, 21(2), 183–186.
Kleger, A., Busch, T., Liebau, S., Prelle, K., Paschke, S., Beil, M., et al. (2007). The bioactive lipid sphingosylphosphorylcholine induces differentiation of mouse embryonic stem cells and human promyelocytic leukaemia cells. Cellular Signalling, 19(2), 367–377.
Kleger, A., Seufferlein, T., Malan, D., Tischendorf, M., Storch, A., Wolheim, A., et al. (2010). Modulation of calcium-activated potassium channels induces cardiogenesis of pluripotent stem cells and enrichment of pacemaker-like cells. Circulation, 122(18), 1823–1836. doi:10.1161/CIRCULATIONAHA.110.971721.
Aasen, T., Raya, A., Barrero, M. J., Garreta, E., Consiglio, A., Gonzalez, F., et al. (2008). Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nature Biotechnology, 26(11), 1276–1284.
Linta, L., Stockmann, M., Kleinhans, K. N., Bockers, A., Storch, A., Zaehres, H., et al. (2011). Rat embryonic fibroblasts improve reprogramming of human keratinocytes into induced pluripotent stem cells. Stem Cells and Development. doi:10.1089/scd.2011.0026.
Sommer, C. A., Stadtfeld, M., Murphy, G. J., Hochedlinger, K., Kotton, D. N., & Mostoslavsky, G. (2009). Induced pluripotent stem cell generation using a single lentiviral stem cell cassette. Stem Cells, 27(3), 543–549.
Gauthaman, K., Fong, C. Y., & Bongso, A. (2010). Effect of ROCK inhibitor Y-27632 on normal and variant human embryonic stem cells (hESCs) in vitro: its benefits in hESC expansion. Stem Cell Reviews, 6(1), 86–95.
Kleger, A., Loebnitz, C., Pusapati, G. V., Armacki, M., Muller, M., Tumpel, S., et al. (2011). Protein kinase D2 is an essential regulator of murine myoblast differentiation. PLoS One, 6(1), e14599. doi:10.1371/journal.pone.0014599.
Liebau, S., Propper, C., Bockers, T., Lehmann-Horn, F., Storch, A., Grissmer, S., et al. (2006). Selective blockage of Kv1.3 and Kv3.1 channels increases neural progenitor cell proliferation. Journal of Neurochemistry, 99(2), 426–437.
Liebau, S., Vaida, B., Proepper, C., Grissmer, S., Storch, A., Boeckers, T. M., et al. (2007). Formation of cellular projections in neural progenitor cells depends on SK3 channel activity. Journal of Neurochemistry, 101(5), 1338–1350.
Azoitei, N., Kleger, A., Schoo, N., Thal, D. R., Brunner, C., Pusapati, G. V., et al. (2011). Protein kinase D2 is a novel regulator of glioblastoma growth and tumor formation. Neuro-Oncology, 13(7), 710–724. doi:10.1093/neuonc/nor084.
Azoitei, N., Pusapati, G. V., Kleger, A., Moller, P., Kufer, R., Genze, F., et al. (2010). Protein kinase D2 is a crucial regulator of tumour cell-endothelial cell communication in gastrointestinal tumours. Gut, 59(10), 1316–1330. doi:10.1136/gut.2009.206813.
Liebau, S., Proepper, C., Schmidt, T., Schoen, M., Bockmann, J., & Boeckers, T. M. (2009). ProSAPiP2, a novel postsynaptic density protein that interacts with ProSAP2/Shank3. Biochemical and Biophysical Research Communications, 385(3), 460–465. doi:10.1016/j.bbrc.2009.05.098.
Liebau, S., Steinestel, J., Linta, L., Kleger, A., Storch, A., Schoen, M., et al. (2011). An SK3 channel/nWASP/Abi-1 complex is involved in early neurogenesis. PLoS One, 6(3), e18148. doi:10.1371/journal.pone.0018148.
Liebau, S., Vaida, B., Storch, A., & Boeckers, T. M. (2007). Maturation of synaptic contacts in differentiating neural stem cells. Stem Cells, 25(7), 1720–1729.
Liangzhi Xie, A.-P. Z., Zheng, L., & Zhou, W. (2006). Cell culture technology for pharmaceutical and cell-based therapies. Taylor & Francis Group. Boca Raton: CRC Press.
Hescheler, J., Fleischmann, B. K., Lentini, S., Maltsev, V. A., Rohwedel, J., Wobus, A. M., et al. (1997). Embryonic stem cells: A model to study structural and functional properties in cardiomyogenesis. Cardiovascular Research, 36(2), 149–162.
Kolossov, E., Lu, Z., Drobinskaya, I., Gassanov, N., Duan, Y., Sauer, H., et al. (2005). Identification and characterization of embryonic stem cell-derived pacemaker and atrial cardiomyocytes. The FASEB Journal, 19(6), 577–579. doi:10.1096/fj.03-1451fje.
Schulz, T. C., Palmarini, G. M., Noggle, S. A., Weiler, D. A., Mitalipova, M. M., & Condie, B. G. (2003). Directed neuronal differentiation of human embryonic stem cells. BMC Neuroscience, 4, 27.
Messana, J. M., Hwang, N. S., Coburn, J., Elisseeff, J. H., & Zhang, Z. (2008). Size of the embryoid body influences chondrogenesis of mouse embryonic stem cells. Journal of Tissue Engineering and Regenerative Medicine, 2(8), 499–506.
Dhara, S. K., & Stice, S. L. (2008). Neural differentiation of human embryonic stem cells. Journal of Cellular Biochemistry, 105(3), 633–640.
Chin, M. H., Mason, M. J., Xie, W., Volinia, S., Singer, M., Peterson, C., et al. (2009). Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell, 5(1), 111–123.
Deng, J., Shoemaker, R., Xie, B., Gore, A., LeProust, E. M., Antosiewicz-Bourget, J., et al. (2009). Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming. Nature Biotechnology, 27(4), 353–360.
Doi, A., Park, I. H., Wen, B., Murakami, P., Aryee, M. J., Irizarry, R., et al. (2009). Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nature Genetics, 41(12), 1350–1353.
Pick, M., Stelzer, Y., Bar-Nur, O., Mayshar, Y., Eden, A., & Benvenisty, N. (2009). Clone- and gene-specific aberrations of parental imprinting in human induced pluripotent stem cells. Stem Cells, 27(11), 2686–2690.
Marchetto, M. C., Yeo, G. W., Kainohana, O., Marsala, M., Gage, F. H., & Muotri, A. R. (2009). Transcriptional signature and memory retention of human-induced pluripotent stem cells. PLoS One, 4(9), e7076.
Bondue, A., Lapouge, G., Paulissen, C., Semeraro, C., Iacovino, M., Kyba, M., et al. (2008). Mesp1 acts as a master regulator of multipotent cardiovascular progenitor specification. Cell Stem Cell, 3(1), 69–84.
Moskowitz, I. P., Kim, J. B., Moore, M. L., Wolf, C. M., Peterson, M. A., Shendure, J., et al. (2007). A molecular pathway including Id2, Tbx5, and Nkx2-5 required for cardiac conduction system development. Cell, 129(7), 1365–1376.
Ching, Y. H., Ghosh, T. K., Cross, S. J., Packham, E. A., Honeyman, L., Loughna, S., et al. (2005). Mutation in myosin heavy chain 6 causes atrial septal defect. Nature Genetics, 37(4), 423–428.
Christoffels, V. M., Smits, G. J., Kispert, A., & Moorman, A. F. (2010). Development of the pacemaker tissues of the heart. Circulation Research, 106(2), 240–254.
Garcia-Frigola, C., Shi, Y., & Evans, S. M. (2003). Expression of the hyperpolarization-activated cyclic nucleotide-gated cation channel HCN4 during mouse heart development. Gene Expression Patterns, 3(6), 777–783.
Mommersteeg, M. T., Hoogaars, W. M., Prall, O. W., de Gier-de, V. C., Wiese, C., Clout, D. E., et al. (2007). Molecular pathway for the localized formation of the sinoatrial node. Circulation Research, 100(3), 354–362.
Stieber, J., Herrmann, S., Feil, S., Loster, J., Feil, R., Biel, M., et al. (2003). The hyperpolarization-activated channel HCN4 is required for the generation of pacemaker action potentials in the embryonic heart. Proceedings of the National Academy of Sciences of the United States of America, 100(25), 15235–15240.
Bettiol, E., Sartiani, L., Chicha, L., Krause, K. H., Cerbai, E., & Jaconi, M. E. (2007). Fetal bovine serum enables cardiac differentiation of human embryonic stem cells. Differentiation, 75(8), 669–681. doi:10.1111/j.1432-0436.2007.00174.x.
Taha, M. F., & Valojerdi, M. R. (2008). Effect of bone morphogenetic protein-4 on cardiac differentiation from mouse embryonic stem cells in serum-free and low-serum media. International Journal of Cardiology, 127(1), 78–87. doi:10.1016/j.ijcard.2007.04.173.
Takei, S., Ichikawa, H., Johkura, K., Mogi, A., No, H., Yoshie, S., et al. (2009). Bone morphogenetic protein-4 promotes induction of cardiomyocytes from human embryonic stem cells in serum-based embryoid body development. American Journal of Physiology. Heart and Circulatory Physiology, 296(6), H1793–H1803. doi:10.1152/ajpheart.01288.2008.
Gissel, C., Doss, M. X., Hippler-Altenburg, R., Hescheler, J., & Sachinidis, A. (2006). Generation and characterization of cardiomyocytes under serum-free conditions. Methods in Molecular Biology, 330, 191–219. doi:10.1385/1-59745-036-7:191.
Kouskoff, V., Lacaud, G., Schwantz, S., Fehling, H. J., & Keller, G. (2005). Sequential development of hematopoietic and cardiac mesoderm during embryonic stem cell differentiation. Proceedings of the National Academy of Sciences of the United States of America, 102(37), 13170–13175. doi:10.1073/pnas.0501672102.
Tran, T. H., Wang, X., Browne, C., Zhang, Y., Schinke, M., Izumo, S., et al. (2009). Wnt3a-induced mesoderm formation and cardiomyogenesis in human embryonic stem cells. Stem Cells, 27(8), 1869–1878. doi:10.1002/stem.95.
Pfaff, N., Lachmann, N., Kohlscheen, S., Sgodda, M., Arauzo-Bravo, M. J., Greber, B., et al. (2011). Efficient hematopoietic redifferentiation of induced pluripotent stem cells derived from primitive murine bone marrow cells. Stem Cells and Development. doi:10.1089/scd.2011.0010.
Bar-Nur, O., Russ, H. A., Efrat, S., & Benvenisty, N. (2011). Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet Beta cells. Cell Stem Cell, 9(1), 17–23. doi:10.1016/j.stem.2011.06.007.
Polo, J. M., Liu, S., Figueroa, M. E., Kulalert, W., Eminli, S., Tan, K. Y., et al. (2010). Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nature Biotechnology, 28(8), 848–855. doi:10.1038/nbt.1667.
Kattman, S. J., Witty, A. D., Gagliardi, M., Dubois, N. C., Niapour, M., Hotta, A., et al. (2011). Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell, 8(2), 228–240.
Stocker, M. (2004). Ca(2+)-activated K+ channels: Molecular determinants and function of the SK family. Nature Reviews Neuroscience, 5(10), 758–770.
Herrmann, S., Fabritz, L., Layh, B., Kirchhof, P., & Ludwig, A. (2011). Insights into sick sinus syndrome from an inducible mouse model. Cardiovascular Research, 90(1), 38–48. doi:10.1093/cvr/cvq390.
Xue, T., Cho, H. C., Akar, F. G., Tsang, S. Y., Jones, S. P., Marban, E., et al. (2005). Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: insights into the development of cell-based pacemakers. Circulation, 111(1), 11–20. doi:10.1161/01.CIR.0000151313.18547.A2.
Liebau, S., Tischendorf, M., Ansorge, D., Linta, L., Stockmann, M., Weidgang, C., et al. (2011). An inducible expression system of the calcium-activated potassium channel 4 to study the differential impact on embryonic stem cells. Stem Cells Int, 2011, 456815. doi:10.4061/2011/456815.
Miake, J., Marban, E., & Nuss, H. B. (2002). Biological pacemaker created by gene transfer. Nature, 419(6903), 132–133. doi:10.1038/419132b.
Lieu, D. K., Chan, Y. C., Lau, C. P., Tse, H. F., Siu, C. W., & Li, R. A. (2008). Overexpression of HCN-encoded pacemaker current silences bioartificial pacemakers. Heart Rhythm, 5(9), 1310–1317. doi:10.1016/j.hrthm.2008.05.010.
Kleger, A., Liebau, S., Lin, Q., von Wichert, G., & Seufferlein, T. (2011). The impact of bioactive lipids on cardiovascular development. Stem Cells Int, 2011, 916180. doi:10.4061/2011/916180.
Yu, J., Hu, K., Smuga-Otto, K., Tian, S., Stewart, R., Slukvin, I. I., et al. (2009). Human induced pluripotent stem cells free of vector and transgene sequences. Science, 324(5928), 797–801. doi:10.1126/science.1172482.
Acknowledgements
The authors would like to thank Ralf Köhntop, Clair Weidgang and Sabine Seltenheim for excellent technical assistance. Alexander Kleger is supported by a fellowship provided by the Medical Faculty of Ulm University (Bausteinprogramm, L.SBR.0011). Main part of this study was funded by the Deutsche Forschungsgemeinschaft (DFG) (S.L., T.B. SFB 497) and (DFG BO1718/4-1) to S.L. and T.B. Part of this work was funded by a grant of the DFG Priority Program 1356 to M.Z. and a grant from the DFG to C.B. (BR-2891/4-1). M.W. is supported by “Deutsche Stiftung für Herzforschung” Projekt Nr. F/08/07 (BIOCARD). B. F. was supported by a grant of the DFG (FL 276/3-3) and a grant of the EU FP7 consortium CardioCell No223372.
Conflict of Interest Disclosures
None
Author information
Authors and Affiliations
Corresponding authors
Additional information
Martin Müller and Marianne Stockmann contributed equally to this work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Supplementary Figure 1
FACS controls. (A-B) Unstained negative controls for control (A) and EBIO treated (B) CRG8 cultures at day 4+10+2 for FACS analyses were performed with cells labeled with secondary antibodies. No primary antibodies were added. (AVI 8.46 mb)
Supplementary Figure 2
Morphology of different murine iPSCs and expression of pluripotency markers. (A) Nanog-GFP (NGFP) cells exhibit typical ES cell colony morphology. Nanog positivity is shown via the endogenous EGFP reporter signal (green) (B) NGFP cells stain positive for SSEA1 (red). Nanog-EGFP (green). (C) TiPS cells exhibit typical ES cell colony morphology and (D) stain positive for SSEA1 (red). Scale bars, 10 μm. (AVI 8.09 mb)
Supplementary Figure 3
TiPS cells express SKCas on protein level. Immunocytochemistry of SKCa proteins. 48 hours after plating, undifferentiated NGFP cells were co-stained for F-actin (green), the indicated SKCa subtype (red); Scale bars, 5μm. (AVI 8.38 mb)
Supplementary Figure 4
SKCa-activation inhibits proliferation of murine iPSCs. (A) Monolayer assay of iPSCs. Undifferentiated iPSCs were cultured in leukemia inhibitory factor-containing medium. After seeding equal numbers of cells (5000 cells/cm2), EBIO was added and replaced every other day. (B-C) Proliferation/viability assay of EBIO-treated (EBIO) and untreated (Con) iPSCs. (B, NGFP and C, TiPS). (D) SKCa-activation induces G1 arrest in NGFP iPSCs cells and diminishes cells in S phase. Representative cell-cycle distribution blots are shown. (E) Quantification of cell cycle analysis data. (PDF 35 kb)
Supplementary Figure 5
SKCa-activation induces cardiac pacemaker-like cells from mouse iPSCs. NGFP (left column) and TIPS cells (right column) (A) 4-day-old (4d) EBs were plated and assayed as indicated. EB outgrowths were analyzed for mRNA levels. qPCR for Mesp1 (B) and Nkx2.5 (C). (D-E) Expression of early and mature pacemaker-like cell genes in control and EBIO-treated variants shown for Isl1 (D) and Cx30.2 (E) (n = 3). (PDF 29 kb)
Supplementary Figure 6
SKCa-activation induces cardiac pacemaker-like cells from mouse iPSCs (TiPS cells). (A) 4-day-old (4d) EBs were plated and assayed as indicated. EBIO was withdrawn on day 10. Culture days after EBIO removal are refereed as day 4+10. EB outgrowths were analyzed for mRNA levels and immunocytochemistry. (B-C) Induction of the cardiac marker gene Myh6 (B) and pacemaker gene (C, Hcn4) in TIPS cells. (D) Induction of HCN4 protein expression upon SKCa-activation and enhanced cardiac differentiation upon SKCa-activation in TiPS cells. Immunocytochemistry for HCN4 (red) and α-actinin (green) at day 4+10 cultures. Scale bars, 20 μm. (PDF 327 kb)
Supplementary Figure 7
SKCa-activation induces cardiac differentiation and pacemaker specification under virtually serum-free conditions in murine iPSCs. (A) 4-day-old (4d) EBs derived from NGFP iPSCs were plated and assayed as indicated. EBIO was withdrawn on day 10. Culture days after EBIO removal are refereed as day 4+10. (B-C) Induction of cardiac and pacemaker genes after SKCa-activation. qPCR for Myh6 (B) and Hcn4 (C) expression (n = 4). (D) Induction of the cardiac protein α-actinin and the pacemaker protein Hcn4 after SKCa-activation by EBIO-treatment. Immunocytochemistry for α-actinin (green) and Hcn4 (red) at indicated time points (n = 3). Scale bars, 20 μm. (PDF 192 kb)
Rights and permissions
About this article
Cite this article
Müller, M., Stockmann, M., Malan, D. et al. Ca2+ Activated K Channels-New Tools to Induce Cardiac Commitment from Pluripotent Stem Cells in Mice and Men. Stem Cell Rev and Rep 8, 720–740 (2012). https://doi.org/10.1007/s12015-011-9324-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12015-011-9324-9